Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SECURE: Isavuconazole vs Voriconazole in Invasive Aspergillosis
NCT00412893Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Mar 2007
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 26
01
Overview
A Phase 3 trial of isavuconazole in invasive aspergillosis (IA), invasive fungal disease (IFD), sponsored by Astellas Pharma. Started Mar 2007; status: completed.
02
Drugs
isavuconazole
03
Conditions
invasive aspergillosis (IA)invasive fungal disease (IFD)
Beyond the preview
Go deeper on NCT00412893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00412893.